Key Events This Week
7 Sep: Downgrade to Strong Sell announced
8 Sep: Stock drops 3.63% following downgrade
10 Sep: Hits lower circuit amid heavy selling pressure
11 Sep: Week closes at Rs.127.05, down 2.90%

Parnax Lab Ltd Locks at Lower Circuit With 20% Loss — Sellers Queue, No Buyers in Sight
2026-09-10 10:00:12At Rs 104.00, sellers were still queuing — but there were no buyers willing to take the other side. Parnax Lab Ltd locked at its lower circuit of 20% on 09 Sep 2026, with unfilled sell orders and a frozen price, signalling a severe imbalance in supply and demand.
Read full news article
Parnax Lab Ltd Downgraded to Strong Sell Amid Technical and Financial Weakness
2026-09-08 08:10:53Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 7 September 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial performance, and valuation concerns, despite some long-term growth achievements. The company’s Mojo Score now stands at 26.0, signalling heightened caution for investors.
Read full news article
Parnax Lab Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges
2026-09-02 08:06:28Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Strong Sell to Sell as of 1 September 2026. This adjustment reflects a complex interplay of technical signals, valuation metrics, financial trends, and overall quality assessments, signalling caution for investors despite some positive price momentum.
Read full news article
Parnax Lab Ltd is Rated Strong Sell
2026-09-01 10:10:57Parnax Lab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Parnax Lab Ltd Downgraded to Strong Sell Amid Weak Financial and Technical Trends
2026-08-18 08:07:34Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Aug 2026. This revision reflects deteriorating financial trends, weakening technical indicators, and valuation concerns, signalling caution for investors amid a challenging operating environment.
Read full news article








